Why Pharma and Medical Device Companies Need Modeling & Simulation, Upcoming Webinar Hosted by Xtalks

Share Article

In this free webinar, the featured speaker will will show how in-silico methods can reduce reliance on animal models and human clinical trial data, accelerate innovation and improve quality design and patient safety. Attendees will learn about the power of modeling and simulation for pharma and medical device companies, and why it’s so important in today’s Life Sciences industry.

Innovating while simultaneously reducing the time and cost of bringing products to market are critical to the financial stability and growth of life science companies.

Today’s pharmaceutical and medical device companies are facing rising pressure from healthcare communities with patients needing more personalized care, consumers and policy makers pushing to lower healthcare costs, the drive to reduce time and costs to bring new products to market, and complying with increasingly onerous regulations. Meanwhile, the industry is focused on developing more innovative products that improve patient outcomes while decreasing healthcare costs. How does a pharmaceutical or medical device company even begin to try and achieve all these objectives?

Innovating while simultaneously reducing the time and cost of bringing products to market are critical to the financial stability and growth of life science companies. And achieving these goals, without sacrificing quality and patient safety is a prerequisite that is extremely hard to satisfy. This has prompted companies to develop ways of improving the total product realization by examining the processes of development, preclinical verification and validation (V&V), clinical studies, regulatory compliance, manufacturing, sourcing, and others.

New life-changing and life-saving products are being developed by companies across the globe. In order for the FDA to achieve their mission of bringing innovative and safe therapies to patients, the industry needs to find a balance between the amount and type of testing and the number of patients necessary to evaluate the experimental therapies, as well as rely on other scientific data sources such as computational models.

Join Karl D’Sousa, Life Sciences Industry Solution Experience Director, Dassault Systèmes in a live webinar on Tuesday, October 27, 2020 at 1pm EDT.

For more information or to register for this event, visit Why Pharma and Medical Device Companies Need Modeling & Simulation.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sydney Perelmutter
Xtalks
+1 (416) 977-6555 x 352
Email >
Visit website